| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V53290 | Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) | 1678417-57-6 | Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) is a 29-amino acid (AA) chimeric peptide synthesized by adding a nonylarginine motif to the carboxyl terminus of rabies virus glycoprotein (RVG). |
|
V54357 | Docaravimab | 2247196-23-0 | Docaravimab is an antibody that targets epitope G-III of the extracellular domain of the ERA (Evelyn-Rockitniki-Abelseth) glycoprotein. |
|
V52087 | Foravirumab (CR4098) | 944548-38-3 | Foravirumab (CR4098) is a monoclonal antibody (mAb) targeting antigenic site III of the rabies virus glycoprotein and may be utilized in rabies research. |
|
V2214 | GRP 60367 | 1309241-34-6 | GRP 60367 is a novel,potent and selective rabies virus (RABV) entry inhibitor with nanomolar potency against some RABV strains. |
|
V52042 | GRP-60367 hydrochloride | 2803211-60-9 | GRP-60367 HCl is a first-in-class small molecule rabies virus (RABV) entry inhibitor (antagonist) with nanomolar effects against certain RABV strains. |
|
V51806 | Mazorelvimab (SYN023) | 2419087-89-9 | Mazorelvimab (SYN023) is a hybrid anti-rabies virus (RABV) humanized monoclonal antibody (mAb) consisting of CTB011 and CTB012. |
|
V54358 | Ormutivimab (NM57; rhRIG) | 2449086-91-1 | Ormutivimab (rhRIG) is a recombinant human monoclonal antibody (mAb) targeting rabies virus. |
|
V81272 | Rabies Virus Glycoprotein | Rabies Virus Glycoprotein is a cell-penetrable peptide consisting of 29 amino acid (AA) residues, derived from rabies virus glycoprotein, which can cross the BBB (blood-brain barrier) and enter brain cells. | |
|
V76569 | Rabies Virus Glycoprotein TFA | Rabies Virus Glycoprotein (TFA) is a cell-penetrable peptide consisting of 29 amino acid (AA) residues, derived from rabies virus glycoprotein, which can cross the BBB (blood-brain barrier) and enter brain cells. | |
|
V39200 | Rafivirumab (CR57) | 944548-37-2 | Rafivirumab (CR57) is an anti-rabies virus monoclonal antibody (mAb) used to prevent rabies. |
|
V35104 | Zamerovimab (CTB011; SYN023) | 2419087-87-7 | Zamerovimab (CTB011; SYN023) is a humanized monoclonal antibody (mAb) cocktail consisting of CTB011 and CTB012. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
